Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 453 is annotated as a long intergenic non-coding RNA (lincRNA), which is defined as a non-coding RNA transcript longer than 200 nucleotides located between protein-coding genes and not overlapping them[3][4]. LincRNAs are implicated in regulating gene expression through various mechanisms, including chromatin modification, transcription regulation, scaffolding protein complexes, and acting as decoys for regulatory molecules[1][2][3]. Only a minority of human lincRNAs have been experimentally characterized, and as of this time, there is no published functional or disease-association data for long intergenic non-protein coding RNA 453 specifically. Like many lincRNAs, it may have tissue-specific expression and could play roles in fine-tuning nearby or distal gene activity, but its exact biological functions remain uncharacterized[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 453.